(Q53752730)

19 May 2018

title

Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients. (English)

1 reference

19 May 2018

0 references

3

Matthias Blüher

1 reference

19 May 2018

Uta Greifenhagen

1

1 reference

19 May 2018

Andrej Frolov

series ordinal

2

1 reference

19 May 2018

Ralf Hoffmann

series ordinal

4

1 reference

19 May 2018

language of work or name

English

0 references

publication date

28 May 2016

1 reference

19 May 2018

Analytical and Bioanalytical Chemistry

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 May 2018

volume

408

1 reference

19 May 2018

issue

20

1 reference

19 May 2018

page(s)

5557-5566

1 reference

19 May 2018

https://scigraph.springernature.com/pub.10.1007/s00216-016-9651-4

exact match

0 references

cites work

Protein glycation, diabetes, and aging

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Use of 13C labeling and NMR spectroscopy for the investigation of degradation pathways of Amadori compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Comprehensive analysis of maillard protein modifications in human lenses: effect of age and cataract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Advanced glycation endproducts: what is their relevance to diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Molecular basis of arterial stiffening: role of glycation - a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Analysis of glycated and ascorbylated proteins by gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Oxidative degradation of N(ε)-fructosylamine-substituted peptides in heated aqueous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Advanced glycation end products of beta2-microglobulin in uremic patients as determined by high resolution mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

An automated multidimensional protein identification technology for shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Statistical design of quantitative mass spectrometry-based proteomic experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Advances in proteomic workflows for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Site specific modification of the human plasma proteome by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-016-9651-4

10.1007/S00216-016-9651-4

21 January 2018

Identifiers

DOI

1 reference

19 May 2018

PubMed ID

27236317

1 reference

19 May 2018